 Irwin Naturals Inc. CSE:IWIN and Braxia Scientific Corp. CSE:BRAX, OTC:BRAXF have signed a Letter of Intent LOI entering into a partnership to launch Clinical Research Services across Irwins growing US-based network of clinics, Emergence. Under the LOI, Irwin will invest up to 2 million over the next 12 months to launch initial research services beginning with at least five clinics in Florida. 